Canine health product containing antibodies against canine parvovirus type 2
The present invention relates to a composition which includes antibodies against one or more specified virus, bacteria and/or pathogen for use to improve dog health, wherein the composition is administered before 24 hours of age of the dog or between 24 hours and up to 90 days of age of the dog.
1. A method of improving dog health, the method comprising orally administering to a dog a composition containing antibodies against Canine parvovirus type 2 in combination with antibodies against one of the following;
Canine coronavirus,
E. coli,
Canine Herpesvirus,
optionally, also in combination with antibodies against one or more of the following:
Bordetella bronchiseptica
Giardial
Canine parainfluenza virus,
Canine distemper virus,
Adenovirus type 1,
Streptococci,
Staphylococci or
Isospora;
wherein the oral administration occurs at least once during the first 24 hours of the dog's life and at least every three days between 48 hours of age and 60 days of age and wherein the antibodies are produced by a mammal.
2. The method of claim 1 , wherein the composition also comprises a hydrolysable carbohydrate and/or oil.
3. The method of claim 1 , wherein the oral administration occurs at least twice during the first 24 hours of the dog's life.
4. The method of claim 1 , wherein the improvement in the dog's health is an improvement in the dog's digestive immunity.
5. The method of claim 1 , wherein the improvement in the dog's health is an increase in the dog's growth.
6. The method of claim 1 , wherein the improvement in the dog's health is a reduction in the dog's stress.
7. The method of claim 4 , wherein the administration results in an increase in the systemic immunity of the dog.
8. A method for preventing disease or enhancing weight gain in a dog, comprising orally administering to a puppy at least once before 24 hours of age and at least every three days between 48 hours of age and 60 days of age a composition comprising antibodies against canine parvovirus type 2 in combination with antibodies against at least one of canine coronavirus, E. coli , canine herpesvirus, Bordetella bronchiseptica , Giardial, canine parainfluenza virus, canine distemper virus, adenovirus type 1, Streptococci, Staphylococci and/or Isospora , wherein the antibodies are produced by a mammal.